| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A booster dose enhances immunogenicity of the COVID-19 vaccine candidate ChAdOx1 nCoV-19 in aged mice
|
Silva-Cayetano, Alyssa
|
|
|
2 |
3 |
p. 243-262.e8
|
article
|
| 2 |
Bacteriophages, a multi-tool to fight infectious disease
|
Pecetta, Simone
|
|
|
2 |
3 |
p. 209-210
|
article
|
| 3 |
Capturing pathogenic immune cells before they home to brain
|
Steinman, Lawrence
|
|
|
2 |
3 |
p. 214-216
|
article
|
| 4 |
Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis
|
Kaufmann, Max
|
|
|
2 |
3 |
p. 296-312.e8
|
article
|
| 5 |
Life and limb protection with dual anti-thrombotic pathway inhibition: COMPASS ushers in a new day in atherothrombotic risk reduction
|
Verma, Subodh
|
|
|
2 |
3 |
p. 233-242
|
article
|
| 6 |
Maternal to fetal transmission of cancer: implications for molecular tumor testing, immune regulation, and pediatric malignancies
|
Eskander, Ramez N.
|
|
|
2 |
3 |
p. 211-213
|
article
|
| 7 |
Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection
|
Sherina, Natalia
|
|
|
2 |
3 |
p. 281-295.e4
|
article
|
| 8 |
SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity
|
Vogels, Chantal B.F.
|
|
|
2 |
3 |
p. 263-280.e6
|
article
|
| 9 |
Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes
|
Pradenas, Edwards
|
|
|
2 |
3 |
p. 313-320.e4
|
article
|
| 10 |
Targeted phage display-based pulmonary vaccination in mice and non-human primates
|
Staquicini, Daniela I.
|
|
|
2 |
3 |
p. 321-342.e8
|
article
|
| 11 |
Tuberculosis endotypes to guide stratified host-directed therapy
|
DiNardo, Andrew R.
|
|
|
2 |
3 |
p. 217-232
|
article
|
Journal description